Clinical Trial Update: (RIGHT HEART III Study - Right Ventricular Hemodynamic Evaluation and Response to Treatment) [Phase 2]

View source ↗

Summary

The RIGHT HEART III Phase 2 trial evaluating right ventricular hemodynamics and response to treatment in pulmonary arterial hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Snippet

Sponsor: University of Giessen | Conditions: Pulmonary Arterial Hypertension (PAH) | Phase 2 | Status: COMPLETED